CREDIT SUISSE AG/ - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 23 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$722,000
+41.6%
858,000
+71.6%
0.00%
Q3 2021$510,000
-32.5%
500,000
-29.7%
0.00%
Q2 2021$756,000
-83.3%
711,000
-83.8%
0.00%
-100.0%
Q1 2021$4,523,000
+1875.1%
4,400,000
+1660.0%
0.00%
Q4 2020$229,000
-83.7%
250,000
-85.6%
0.00%
-100.0%
Q3 2020$1,401,0001,740,0000.00%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 157,390,000$141,877,0003.17%
Birch Grove Capital LP 8,000,000$7,200,0002.94%
PFM Health Sciences, LP 48,150,000$43,919,0001.64%
SILVERBACK ASSET MANAGEMENT LLC 8,505,000$7,665,0001.04%
DAFNA Capital Management LLC 1,500,000$1,345,0000.35%
DeepCurrents Investment Group LLC 8,696,000$7,756,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 11,092,000$10,005,0000.23%
ADVENT CAPITAL MANAGEMENT /DE/ 9,235,000$8,358,0000.13%
Verition Fund Management LLC 2,441,000$2,227,0000.03%
CAPSTONE INVESTMENT ADVISORS, LLC 6,000,000$5,473,0000.02%
View complete list of AERIE PHARMACEUTICALS INC shareholders